thiopentone on the haemodynamic response to laryngoscopy and intubation. The study was conducted in Soba University and Khartoum Teaching Hospital, in the period from January to May 2006. One hundred patients were selected and divided into two groups (group 1 and group 2) with 50 patients each. Group 1 was given 4mg/kg of thiopentone initially, to induce anaesthesia, and another 4mg/kg of the same drug, following the administration of 1mg/kg of suxamethonium to facilitate endotracheal intubation. Group 2 candidates, the control group, received the usual induction dose of thiopentone only. All patients were premedicated with 0.02 mg/kg atropine IV. Blood pressure (Systolic, diastolic and mean), using Non-Invasive Blood Pressure monitor (NIBP), and heart rate were measured before induction and after intubation.
Results
The use of a second dose of thiopentone significantly attenuated the haemodynamic response to laryngoscopy and intubation in comparison to those who didn't received it. The increase in heart rate, systolic, diastolic and mean arterial pressure in the second dose thiopentone group was 23.14beats/min, 12.44 mmHg, 17.04 mmHg and 18.7 mmHg respectively. Concerning the control group, there was a significant rise in heart rate (32.7beats/minute), systolic (22.52 mmHg), diastolic (24.78 mmHg) and mean arterial pressure (23.7 mmHg) from the preinduction values.
Conclusion
The study showed that giving a second dose of thiopentone significantly attenuated the haemodynamic response to laryngoscopy and intubation without causing undue prolongation in recovery time. Keywords: Thiopentone, second dose, laryngoscopy, intubation, pressor response. Inroduction Laryngoscopy and tracheal intubation, after standard induction dose of thiopentone, often provokes a refer increase in both sympathetic and sympathoadrenal activity, which may result in increased blood pressure, tachycardia and arrhythmia
(1) . The arrhythmogenicity was noticed by Raid in 1940 (2) . while the tachycardia and hypertension were described by King However, the induction dose alone is not sufficient to prevent the pressor response to laryngoscopy and intubation. This study is designed to assess the effect of a second dose of thiopentone, given after the induction dose and just before laryngoscopy and intubation, on the haemodynamic changes aggravated by laryngoscopy and intubation. Methodology This prospective observational study was designed to assess the effect of a second dose of thiopentone on haemodynamic response to laryngoscopy and intubation. The study was conducted in Soba University and Khartoum Teaching Hospital, in the period from January to May 2006. One hundred patients, undergoing elective surgical procedures and needing endotracheal intubation were randomly selected and allocated into two groups. Patients in group 1 (50 patients) received a second dose of thiopentone after induction of anaesthesia and before intubation, while patients in group 2, the control group (50 patients
Patients with intercurrent disease, those taking drugs with cardiovascular effect and those for emergency or day-case surgery were excluded from the study. All patients were seen in the ward at least one day before surgery for preoperative assessment. Each patient"s preoperative heart rate, systolic and diastolic arterial pressure (DAP) were measured, and the mean arterial pressure (MAP) was derived mathematically (MAP=Diastolic + 1/3 pulse pressure). On arrival to the operating theatre, the patients were assigned sequentially to either the second dose thiopentone group or the control group. In the operating room, an intravenous cannula was inserted for fluids and drugs administration and monitors were attached, including noninvasive automatic blood pressure monitor, ECG and pulse oximeter. The pre-induction baseline heart rate, systolic, diastolic and mean arterial blood pressures were measured and values were recorded in the patient's data form. Each patient was premedicated with 0.2 mg atropine and preoxygenated for 3 minutes. Patients in the second dose thiopentone group were given 4 mg/kg thiopentone sodium 2.5% by slow intravenous injection for induction of anaesthesia, followed by 1mg/kg IV suxamethonium chloride to facilitate tracheal intubation. A second dose of thiopentone, equal to the induction dose, was given intravenously just before laryngoscopy and intubation. Patients in the control group (group 2) were only given 4 mg/kg thiopentone sodium by slow intravenous injection for induction of anaesthesia and then I.V suxamethonium chloride 1mg/kg. After adequate relaxation, as judged by loss of lower jaw tone, laryngoscopy was undertaken with Magill long blade laryngoscope and the trachea was intubated with the appropriate size of endotracheal tube. One minute after intubation the heart rate, systolic, diastolic and mean arterial pressure were recorded and were registered in the patient's data form. Cases with difficult and /or repeated laryngoscopy and/or intubation (Attempts taking more than 60 seconds) were excluded from the study. Intubation time in this study was taken as the time from oral introduction of the laryngoscope to successful placement of endotracheal tube. The difference between the pre-induction and post intubation haemodynamic values, in each group, were considered as the surrogate for haemodynamic response to laryngoscopy and intubation. Patient"s data was collected by data form and electronic monitoring. The collected data was analyzed using master sheet and excel computer program and SPSS. The data were then presented in figures and tables. Hypothesis was tested using Chi square and paired t-test and whenever a variable has a P-value <0.05, it was considered significant.
Results
The study recruited one hundred patients fulfilling the inclusion criteria. Selected patients were divided into two equal groups. Group 1 received a second dose of thiopentone while group 2 patients, the control group, did not receive a second dose of this drug. Patients in both groups were comparable in number, age, sex, and weight (Table 1 and 2). Table 3 represents the base line mean haemodynamic values and the haemodynamic changes for both groups following induction of anaesthesia. In the second dose group, the rise in heart rate from the base line value was 23.14 beats/minute, where it was 32.7 beats/minute in the control group (P=0.01). Systolic arterial pressure increase from the base line value was 12.44 mmHg in group 1, while it was 22.52 mmHg in the control group (P=0.0001). The rise in the diastolic arterial pressure from the preinduction value was 17.04 mmHg in the study group, compared to 24.78 mmHg rise in the control group (P=0.0001). The rise of mean arterial pressure from the preinduction value was18.7 mmHg in the second dose groups, while it was 23.7 mmHg in control group (P=0.0001). Differences in pre and post induction haemodynamic values were statistically significant (P< 0.05). Original Article Thiopentone Sitt El-Nissa S Ahmed dose just before laryngoscopy ensures sufficiently high concentration of the drug in the brain to depress cerebral reflexes. Although relatively high dose was selected in this study (8 mg/kg), prolonged recovery time was not observed. It is well known from literature that the incidence of significantly prolonged recovery time is observed when using doses more than 10 mg/kg (15) . Moreover, it is known that the higher the initial doses of thiopentone, the higher the concentration of the brain plasma level at which the patient will wake on. This phenomenon has been termed acute tolerance (16) . Thus the divided dose technique, as used in this study, may be appropriate to mitigate acute tolerance than a single high induction dose technique. In this study, the second dose thiopentone technique significantly attenuated the post intubation rise in heart rate, compared with the control group. Conventional induction dose of thiopentone usually causes a rise in heart rate to compensate for the drug induced fall in blood pressure. The less proportionate increase in heart rate in the second dose thiopentone group after intubation may be due to depression of sympatho-adrenal response cause by increased depth of anaesthesia. In this study atropine was administered to both study groups as a premedicant drug. Atropine increases heart rate, an effect noted in both groups. This is expected to alter the measurement of the heart rate and to some extent other haemodynamic variables. On the other hand, the use of atropine is necessary in this study to overcome the effect of both suxamethonium and thiopentone on the heart. Despite this fact, the use of atropine in this study had no remarkable influence on post induction heart rate. In this study, the increase in systolic and diastolic arterial pressures in second dose group was consistent with the findings of Takkune and Cowarker (17) who used thiopentone 1mg/kg and 2.5 mg/kg just before laryngoscopy and intubation. They found that both doses of thiopentone reduced the haemodynamic values close to their initial levels. The mean arterial pressure in the second dose thiopentone group increased, following laryngoscopy and intubation, by only 18.7 mmHg from the preinduction value, compared with 23.7 mmHg increase in the control group. This is compatible with the findings of Unni (18) and Cowarker who used the second dose thiopentone at a dose of 2.5 mg/kg over 30 seconds before laryngoscopy. In conclusion, the second dose thiopentone technique, used in this study, is appropriate for mitigation of acute tolerance to thiopentone than the single induction dose technique. The second dose thiopentone, as used in this study, significantly attenuated the post intubation rise in haemodynamic variables seen after laryngoscopy and intubation. Attenuation of the systolic arterial pressure was more remarkable than that seen with diastolic, mean or heart rate. The use of a second dose of thiopentone is recommended to mitigate the haemodynamic response to laryngoscopy and intubation in hypertensive, cardiac, those with aneurysm and atherosclerotic patients.
